111

MOLECURE SPOLKA AKCYJNA

No trades
See on Supercharts

1B1 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Molecure SA engages in the discovery and development of small molecules for the treatment of unmet medical needs. It offers a platform of distinct small molecule programs targeting chitinases and chitinase-like-proteins, with potential utility in diverse inflammatory and fibrotic diseases. The company was founded by Stanislaw Wieslaw Pikul and Adam Golebiowski on March 12, 2012 and is headquartered in Warsaw, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

1B1 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company